Clinical Trial Update: Vonoprazan-containing Triple Therapy Versus Empiric Bismuth Quadruple Therapy for First-line Helicobacter Pylori Treatment: a Randomized Clinical Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial compares vonoprazan-containing triple therapy to empiric bismuth quadruple therapy as first-line treatment for Helicobacter pylori in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• empiric bismuth quadruple therapy
• vonoprazan-containing triple therapy

Snippet

Sponsor: Shanghai East Hospital | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: UNKNOWN